These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7674596)

  • 1. Administration of AGEs in vivo induces genes implicated in diabetic glomerulosclerosis.
    Yang CW; Vlassara H; Striker GE; Striker LJ
    Kidney Int Suppl; 1995 Jun; 49():S55-8. PubMed ID: 7674596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of AGEs in vivo induces extracellular matrix gene expression.
    Striker LJ; Striker GE
    Nephrol Dial Transplant; 1996; 11 Suppl 5():62-5. PubMed ID: 9044310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of glomerular extracellular matrix and growth factor mRNA in rapid and slowly progressive glomerulosclerosis: studies in mice transgenic for native or mutated growth hormone.
    Yang CW; Striker GE; Chen WY; Kopchick JJ; Striker LJ
    Lab Invest; 1997 Apr; 76(4):467-76. PubMed ID: 9111509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products.
    Zheng F; He C; Cai W; Hattori M; Steffes M; Vlassara H
    Diabetes Metab Res Rev; 2002; 18(3):224-37. PubMed ID: 12112941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribozyme targeting of receptor for advanced glycation end products in mouse mesangial cells.
    Tsuji H; Iehara N; Masegi T; Imura M; Ohkawa J; Arai H; Ishii K; Kita T; Doi T
    Biochem Biophys Res Commun; 1998 Apr; 245(2):583-8. PubMed ID: 9571198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
    Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors.
    Sugimoto H; Grahovac G; Zeisberg M; Kalluri R
    Diabetes; 2007 Jul; 56(7):1825-33. PubMed ID: 17456853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.
    Yang CW; Vlassara H; Peten EP; He CJ; Striker GE; Striker LJ
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9436-40. PubMed ID: 7937785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of glomerular diseases in renal biopsies: initial results of a collaborative international study. The International Study Group for Molecular Study of Kidney Biopsies.
    Esposito C; Striker LJ; Patel A; Peten E; Liu ZH; Sakai H; Striker GE
    Proc Assoc Am Physicians; 1996 May; 108(3):209-17. PubMed ID: 8774054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
    Huang Y; Lin S; Zhou J
    Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen and collagenase mRNAs in normal and sclerotic glomeruli: predictors of progression and response to therapy.
    He CJ; Yang CW; Peten EP; Liu ZH; Patel A; Striker LJ; Striker GE
    Kidney Int Suppl; 1995 Jun; 49():S39-43. PubMed ID: 7674591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.
    Yamamoto Y; Kato I; Doi T; Yonekura H; Ohashi S; Takeuchi M; Watanabe T; Yamagishi S; Sakurai S; Takasawa S; Okamoto H; Yamamoto H
    J Clin Invest; 2001 Jul; 108(2):261-8. PubMed ID: 11457879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes.
    Rüster C; Bondeva T; Franke S; Förster M; Wolf G
    Nephrol Dial Transplant; 2008 Jul; 23(7):2179-91. PubMed ID: 18344241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation.
    Usui HK; Shikata K; Sasaki M; Okada S; Matsuda M; Shikata Y; Ogawa D; Kido Y; Nagase R; Yozai K; Ohga S; Tone A; Wada J; Takeya M; Horiuchi S; Kodama T; Makino H
    Diabetes; 2007 Feb; 56(2):363-72. PubMed ID: 17259380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
    Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
    Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta.
    Kim YS; Kim BC; Song CY; Hong HK; Moon KC; Lee HS
    J Lab Clin Med; 2001 Jul; 138(1):59-68. PubMed ID: 11433229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Different expressions of alpha 2 (IV) and alpha 3 (IV) collagen mRNAs in renal glomeruli of IgA nephropathy].
    Zheng F; Li L; Liu Z
    Zhonghua Yi Xue Za Zhi; 1995 Apr; 75(4):197-200, 253. PubMed ID: 7788546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitory effect of elastase on diabetic nephropathy in experimental diabetic mice].
    Fujii W
    Hokkaido Igaku Zasshi; 2002 Sep; 77(5):429-38. PubMed ID: 12404758
    [No Abstract]   [Full Text] [Related]  

  • 19. SPARC gene expression is increased in diabetes-related mesenteric vascular hypertrophy.
    Jandeleit-Dahm K; Rumble J; Cox AJ; Kelly DJ; Dziadek M; Cooper ME; Gilbert RE
    Microvasc Res; 2000 Jan; 59(1):61-71. PubMed ID: 10625572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular changes in the KK-Ay/Ta mouse: a possible model for human type 2 diabetic nephropathy.
    Ito T; Tanimoto M; Yamada K; Kaneko S; Matsumoto M; Obayashi K; Hagiwara S; Murakoshi M; Aoki T; Wakabayashi M; Gohda T; Funabiki K; Maeda K; Horikoshi S; Tomino Y
    Nephrology (Carlton); 2006 Feb; 11(1):29-35. PubMed ID: 16509929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.